Insulin Sensitivity & Metabolic Health Stack
- Category
- Weight Loss & Metabolism
- Purpose
- Blood Sugar Regulation & Metabolic Optimization
- Peptides
- MOTS-cBPC-157Semaglutide
Why these peptides work together
Semaglutide handles systemic insulin management and appetite via central GLP-1 signaling. MOTS-c works at the cellular level to improve how muscles and fat tissue respond to insulin, independent of GLP-1 pathways. BPC-157 protects the GI tract (important given semaglutide's GI side effects) and may reduce the chronic low-grade inflammation that underpins metabolic syndrome.
Semaglutide handles appetite and blood sugar from the brain's side, MOTS-c helps your cells use insulin better from the inside, and BPC-157 protects your gut from the side effects the other two can cause.
⚠️ This page describes a combination of compounds that are, with few exceptions, not approved by the FDA for any use. It records protocols described in research and community sources. It is not a recommendation, not a prescription, and not medical advice. Combining compounds multiplies the unknowns rather than adding them. Do not act on anything here without a qualified healthcare professional who knows your history.